Infectious Diseases Research in Dallas
North Texas Infectious Diseases Consultants' Infectious Disease Research Department is one of the leading clinical trial sites in the north Texas region.
All of our infectious diseases clinical trials are conducted in our offices located on the campus of Baylor University Medical Center near downtown Dallas.
We are committed to providing our community with the latest infectious diseases research and treatment options, and to treating each of our patients with the dignity, compassion and respect they deserve.
Our research staff is comprised of some of the most well-respected, board certified Infectious Disease physicians, specially trained physicians assistants, pharmacists and pharmacy technicians, RNs, LVNs and medical assistants in the region to ensure our patients receive the highest possible levels of patient care.
NTIDC's Research Department has participated in multiple trials for Antiretroviral drugs including:
- Protease Inhibitors
- Integrase Inhibitors
- Entry Inhibitors
Our Infectious Disease Research Department also enables us to participate in intense 12-hour pharmacokinetic studies whose outcomes provide important dosing and safety information.
Our Infectious Disease Research Department is currently collaborating with the Baylor Institute of Immunology Research (BIIR) to study a therapeutic vaccine for the treatment of HIV.
We remain committed to our work with pharmaceutical companies on the development of new antiretroviral therapies, vaccine's and the improvement of currently used ART's.
Our research team provides patients with a full spectrum of care including social work referrals, pharmacy support, standard of care and protocol required procedures.
Current Infectious Disease Clinical Trials
We are currently participating in Phases I, II, III and IV clinical trials for the study and treatment of HIV-infected individuals and are proud to offer our patients the latest experimental treatment options available.
Please contact Bryan King at email@example.com for information on our current studies.